Literature DB >> 10421823

Role of respiratory infection in onset of asthma and chronic obstructive pulmonary disease.

F D Martinez1.   

Abstract

There is renewed interest in the possible role of events occurring during early life in determining predisposition to asthma and allergies. Among these events, respiratory illnesses associated with viral infections have been the matter of considerable research interest. There is now evidence suggesting that an immune response to viral infection in early life that is skewed toward an IgE- or an eosinophil-mediated slant is predictive of persistent wheezing symptoms up to the age of 6 years. Genetic and environmental factors (specifically bacterial infection burden) may be important determinants of the maturation of immune responses from a default 'Th-2-like' at birth to mature, non-Th-2-like responses. Homing of Th-2-like responses to the lung may be determined in part by inheritance of bronchial hyperresponsiveness, and in part by the progressive nature of chronic, uncontrolled airway inflammation. The main risk factor for the development of wheezing episodes in children who are not predisposed to allergic asthma is diminished airway function, which can also be detected shortly after birth. These children may stop wheezing later during childhood, but their levels of lung function track with age. It is tempting to speculate that chronic obstructive pulmonary disease may occur more frequently in these children.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421823     DOI: 10.1046/j.1365-2222.1999.00009.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  10 in total

1.  Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

Authors:  K Bendelja; A Gagro; A Bace; R Lokar-Kolbas; V Krsulovic-Hresic; V Drazenovic; G Mlinaric-Galinovic; S Rabatic
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 2.  Improving the management of atopic disease.

Authors:  S T Holgate; G Lack
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

Review 3.  Does a higher number of siblings protect against the development of allergy and asthma? A review.

Authors:  W Karmaus; C Botezan
Journal:  J Epidemiol Community Health       Date:  2002-03       Impact factor: 3.710

Review 4.  Management of asthma in young children.

Authors:  Marianna Sockrider
Journal:  Curr Allergy Asthma Rep       Date:  2002-11       Impact factor: 4.806

5.  Analysis of the lung microbiome in the "healthy" smoker and in COPD.

Authors:  John R Erb-Downward; Deborah L Thompson; Meilan K Han; Christine M Freeman; Lisa McCloskey; Lindsay A Schmidt; Vincent B Young; Galen B Toews; Jeffrey L Curtis; Baskaran Sundaram; Fernando J Martinez; Gary B Huffnagle
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

6.  Early life environmental predictors of asthma age-of-onset.

Authors:  Olivia R Ferry; David L Duffy; Manuel A R Ferreira
Journal:  Immun Inflamm Dis       Date:  2014-07-26

7.  Childhood maltreatment as a risk factor for COPD: findings from a population-based survey of Canadian adults.

Authors:  Margot E Shields; Wendy E Hovdestad; Charles P Gilbert; Lil E Tonmyr
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-10-26

8.  Risk factors and prognosis of recurrent wheezing in Chinese young children: a prospective cohort study.

Authors:  Jing Guo; Wenjing Zhu; Huimin Wang; Patrick G Holt; Guicheng Zhang; Chuanhe Liu
Journal:  Allergy Asthma Clin Immunol       Date:  2019-06-18       Impact factor: 3.406

9.  Risk factors of bronchial asthma in bahrah, saudi arabia.

Authors:  A Al-Mazam; A G Mohamed
Journal:  J Family Community Med       Date:  2001-01

10.  Redecoration of apartments promotes obstructive bronchitis in atopy risk infants--results of the LARS Study.

Authors:  Ulrike Diez; Martina Rehwagen; Ulrike Rolle-Kampczyk; Heide Wetzig; Rita Schulz; Matthias Richter; Irina Lehmann; Michael Borte; Olf Herbarth
Journal:  Int J Hyg Environ Health       Date:  2003-06       Impact factor: 5.840

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.